<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="28460">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01962116</url>
  </required_header>
  <id_info>
    <org_study_id>QUENOT DB 2012</org_study_id>
    <nct_id>NCT01962116</nct_id>
  </id_info>
  <brief_title>Citrate Versus Heparin for the Lock of Non-tunneled Hemodialysis Catheters in Patients Hospitalised in ICU</brief_title>
  <acronym>VERROUREA</acronym>
  <official_title>Citrate Versus Heparin for the Lock of Non-tunneled Hemodialysis Catheters in Patients Hospitalised in ICU = Multicentre, Controlled, Randomised Superiority Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      After obtaining written informed consent and inclusion, patients will be randomised into 2
      groups for the type of dialysis catheter lock:

        -  The first group will have a citrate lock

        -  The second group will have a heparin lock Patients will be stratified according to the
           centre and type of Renal Replacement Therapy (RRT) continuous or intermittent.

      The daily surveillance of patients will be no different from the usual surveillance of
      patients on Renal Replacement Therapy.

      The hemodialysis catheters used will be specific Renal Replacement Therapy catheters.

      The decision to withdraw the catheter will be made by the investigator and based on clinical
      criteria (complications related to the catheter, termination of Renal Replacement Therapy…)
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>Duration average of use without complication</measure>
    <time_frame>up to 28 days</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">386</enrollment>
  <condition>Patients With Acute Renal Insufficiency</condition>
  <arm_group>
    <arm_group_label>Heparin lock</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Citrate lock</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Citrate 4%</intervention_name>
    <arm_group_label>Citrate lock</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>unfractionated heparin</intervention_name>
    <arm_group_label>Heparin lock</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged &gt; 18 years

          -  Requiring RRT for acute renal insufficiency

          -  For which a 1st non-tunneled catheter is placed

          -  In the jugular or femoral position

          -  After written informed consent has been obtained from the patient, a member of the
             family or a person of trust

        Exclusion Criteria:

          -  Patient presenting active poorly controlled bleeding

          -  Known allergy to citrate

          -  Acute liver failure (Prothrombin level &lt;30%)

          -  Thrombopenia &lt; 30 000/mm3

          -  Known or suspected heparin-induced thrombopenia

          -  Known systemic bacterial infection at the time the catheter is placed

          -  catheter in the subclavicular position

          -  Persons not covered by the national health insurance agency

          -  Pregnant womens

          -  Adults under guardianship
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Pierre QUENOT</last_name>
      <phone>03.80.29.36.85</phone>
      <email>jean-pierre.quenot@chu-dijon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 10, 2013</lastchanged_date>
  <firstreceived_date>August 27, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Calcium heparin</mesh_term>
    <mesh_term>Citric Acid</mesh_term>
    <mesh_term>Heparin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
